Ryoncil Kit
Product Images NDC 73648-112

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Ryoncil (NDC 73648-112). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mesoblast, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 mg Vial (Ryoncil 01)

Label for RYONCIL remestemcel-l-rknd KIT, a human prescription drug by Mesoblast. The label includes dosing information (Target 25 x 10^6 cells per 3.8 mL), storage instructions to keep at or below -135°C, and usage notes indicating single-use vial and to discard unused portion. Also shows a placeholder for 2D code, lot number, and expiration date.*

FDA Label Image

1 Vial (Ryoncil 02)

Packaging label for RYONCIL (remestemcel-L-rknd) suspension for IV infusion. The label states it contains allogeneic bone marrow-derived mesenchymal stromal cells with a target concentration of 25 x 10^6 / 3.8 mL (6.68 x 10^6 /mL), intended for single-use intravenous administration after thaw and resuspension. The product is labeled as sterile with no preservative and marked Rx only. The labeler is Mesoblast.*

FDA Label Image

4 Vials (Ryoncil 03)

Packaging label for RYONCIL (remestemcel-L-rknd) suspension for IV infusion. The label indicates it contains allogeneic bone marrow-derived mesenchymal stromal cells, targeted at 25 x 10^6 cells per 3.8 mL. It is a single-use vial for intravenous administration after thaw and resuspension. The product is Rx only, sterile, and contains no preservative. The labeler is Mesoblast.*

FDA Label Image

1 Vial (Ryoncil 04)

Label for RYONCIL remestemcel-l-rknd kit for intravenous infusion containing allogeneic bone marrow-derived mesenchymal stromal cells. The kit is for patient weight under 12.5 kg and includes one single vial carton and one alcohol wipe. Manufactured by Mesoblast, the label details storage instructions, usage directions, and contents including cell count and cryopreservation components. A barcode and regulatory information are also visible.*

FDA Label Image

2 Vial (Ryoncil 05)

Text panel for RYONCIL (remestemcel-l-rknd) suspension for IV infusion kit, detailing contents, patient weight range (12.5 to less than 25 kg), storage instructions, single-use vial directions, cryopreservation ingredients, and manufacturer information including Mesoblast Inc. and U.S. license number.*

FDA Label Image

3 Vial (Ryoncil 06)

Text panel for RYONCIL (remestemcel-l-rknd) kit for IV infusion, containing allogeneic bone marrow-derived mesenchymal stromal cells. Kit is for patients weighing 25 to under 37.5 kg with 3 single vial cartons and 3 alcohol wipes. Instructions include single-use vial disposal, intravenous administration after thawing and resuspension, and storage at ≤ -135°C. Manufactured by Mesoblast Inc., New York.*

FDA Label Image

4 Vial (Ryoncil 07)

Label for RYONCIL remestemcel-l-rknd, a kit for intravenous infusion containing allogeneic bone marrow-derived mesenchymal stromal cells. The kit is designed for patient weights 37.5 to under 50 kg, including a 4-vial carton and 4 alcohol wipes. Manufactured by Mesoblast Inc., New York, it requires thawing and resuspension before use and storage at vapor phase liquid nitrogen temperatures.*

FDA Label Image

5 Vial (Ryoncil 08)

Label for RYONCIL remestemcel-l-rknd suspension for IV infusion, a human prescription drug kit by Mesoblast. The kit is for patient weight 50 to <62.5 kg and contains single vial and 4-vial cartons plus alcohol wipes. The label includes dosage form, storage instructions, sterility info, and manufacturer details.*

FDA Label Image

6 Vial (Ryoncil 09)

The image shows a drug label for RYONCIL (remestemcel-l-rknd) suspension for IV infusion. It details the product as an allogeneic bone marrow-derived mesenchymal stromal cell kit for patient weight 62.5 to less than 75 kg, describing vial contents, storage instructions, and use precautions. The label includes manufacturer information for Mesoblast Inc., barcode, and lot/expiration placeholders.*

FDA Label Image

7 Vial (Ryoncil 10)

Text panel for RYONCIL (remestemcel-l-rknd) kit, a suspension for IV infusion containing allogeneic bone marrow-derived mesenchymal stromal cells. The kit targets patients weighing 75 kg to <87.5 kg and includes multiple single and 4-vial cartons with alcohol wipes. It provides storage, handling, and administration instructions, including thawing, resuspension, and infusion timing. Manufacturer information for Mesoblast is also shown.*

FDA Label Image

8 Vial (Ryoncil 11)

Label for RYONCIL (remestemcel-l-rknd) kit suspension for IV infusion containing allogeneic bone marrow-derived mesenchymal stromal cells. The kit is for patient weight 87.5 to less than 100 kg and includes 2 four-vial cartons and 8 alcohol wipes. Manufactured for Mesoblast Inc, New York, NY. Storage instructions and vial contents are detailed on the label.*

FDA Label Image

8 Vial (Ryoncil 12)

Drug facts label for RYONCIL (remestemcel-l-rknd) kit, a suspension for IV infusion containing allogeneic bone marrow-derived mesenchymal stromal cells. The label details kit contents, storage instructions, usage directions, and manufacturing information from Mesoblast, including a barcode and regulatory identifiers.*

FDA Label Image

8 Vial (Ryoncil 13)

Label for RYONCIL remestemcel-l-rknd suspension for IV infusion, a kit containing allogeneic bone marrow-derived mesenchymal stromal cells. The kit is for patient weight 112.5 to less than 125 kg and includes single and 4-vial cartons plus alcohol wipes. Manufactured by Mesoblast.*

FDA Label Image

8 Vial (Ryoncil 14)

Label for RYONCIL (remestemcel-l-rknd) KIT, a human prescription drug by Mesoblast. The label details suspension for IV infusion with allogeneic bone marrow-derived mesenchymal stromal cells at a target concentration of 25 x 10^6 cells per 3.8 mL. Kit contents include single and 4-vial cartons and alcohol wipes. Storage instructions specify vapor phase liquid nitrogen at or below -135°C. Manufacturer address and regulatory info are also provided.*

FDA Label Image

8 Vial (Ryoncil 15)

RYONCIL kit containing remestemcel-l-rknd, a suspension for IV infusion with allogeneic bone marrow-derived mesenchymal stromal cells. The kit is designed for patient weight 137.5 to less than 150 kg and includes 3 cartons of 4 vials each plus 12 alcohol wipes. Manufactured for Mesoblast Inc, New York.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.